Sylvie Helfré

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 469 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +10

Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists

P. Giraud, S Elles, Sylvie Helfré et al. · Radiotherapy and Oncology · 2002 · 217 citations

Adaptive Radiotherapy, Nuclear Medicine, Radiation Therapy +12

Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing

P. Giraud, Yann De Rycke, Bernard Dubray et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 156 citations

Adaptive Radiotherapy, Medical Imaging, Radiation Therapy +9

Proton Therapy in Pediatric Skull Base and Cervical Canal Low-Grade Bone Malignancies

Jean‐Louis Habrand, R. Schneider, Claire Alapetite et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 67 citations

Neuro-oncology, Pediatric Skull Base, Pediatrics +6

Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects

Daniel Orbach, Hervé J. Brisse, Sylvie Helfré et al. · Pediatric Blood & Cancer · 2007 · 64 citations